Abstract:In our previous studies, we identified 12 multiple myeloma (MM)-associated antigens by serological analysis of tumor-associated antigens with a recombinant cDNA expression library (SEREX) on MM. MM-associated antigen-8 (MMSA-8) was one of the new antigens identified. We determined the 3'- and 5'-ends of MMSA-8 using SMART-rapid amplification of cDNA ends (RACE) and then cloned its full-length cDNA in the U266 cell line. The full cDNA sequence revealed that MMSA-8 is RPS27A-related transcript variant 1 that is specifically associated with MM. We examined its prognostic significance for the first time, by investigating the correlations between MMSA-8 expression and definite clinicopathological features. We quantitatively assessed MMSA-8 expression using qRT-PCR and western blot analysis in healthy donors and MM patients. The expression levels of MMSA-8 were upregulated with statistical significance in MM patients in contrast to those in healthy donors. The expression of MMSA-8 was also upregulated in relapsed patients compared with that in the complete remission (CR) group. Contrasting MMSA-8 expression levels in different patients with definite clinicopathological features suggested an association between MMSA-8 with unfavorable clinicopathological characteristics, such as international staging system (ISS) stage III, higher lactate dehydrogenase (LDH) levels and higher C-reactive protein (CRP) levels. The expression of MMSA-8 was also increased in patients with unfavorable cytogenetic and genetic abnormalities, including the presence of t(11;14), t(4;14), t(14;16), del(17p), del(13q) and p53 deletion, which was statistically significant. The expression of MMSA-8 exhibited significant variance in the treatment responses of the CR, PR, progression and relapse groups. Univariate and multivariate analyses revealed that high MMSA-8 values were associated with poorer progression-free survival (PFS) and overall survival (OS) in MM patients independently. In conclusion, our data indicated that MMSA-8 is an independent and unfavorable prognostic risk factor in MM; MMSA-8 is also a promising diagnostic and therapeutic target in MM patients, but further validation is needed.

Predicting the secondary structure and preparing polyclonal antibody for a novel antigen MMSA-1 in multiple myeloma

Prediction of the Secondary Structure and Analysis of B-cell Epitopes for Eliminated-signal Protein of MSTN in Swine

[Immunological Screening for Multiple Myeloma-Associated Antigens and Their Bioinformatics Analysis].

A novel multi‐epitope vaccine from MMSA‐1 and DKK1 for multiple myeloma immunotherapy

Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma

Prediction of the Common B Cell Epitopes Derived from the Tumor Antigen MAGE-A Sub-Family

Prediction, Synthesis and Identification of HLA-A2-restricted Cytotoxic T Lymphocyte Epitopes of the Tumor Antigen MAGE-n

[Bioinformatic Analysis and Identification for a Novel Antigen MLAA-22 in Acute Monocytic Leukemia].

Preparation and Preliminary Utilization of Monoclonal Antibodies Specifically Against Extracellular Peptide Fragment of Prostate Specific Membrane Antigen

Preparation and Identification of Monoclonal Antibodies Against MATSA

Muc1 Glycopeptide Epitopes Predicted By Computational Glycomics

Proteomic analysis for finding serum pathogenic factors and potential biomarkers in multiple myeloma.

MMSA-1 expression pattern in multiple myeloma and its clinical significance

[The Research on the Expression and Localization of Multiple Myeloma Associated Antigen MMSA-1].

Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.

Preparation and Characterization of Sialyl - mucin Specific Monoclonal Antibodies and their Immunohistochemical Usage in Gastric Cancer and Colorectal Carcinoma

Identification of CD8+ T-cell Epitope from Multiple Myeloma-Specific Antigen AKAP4

Antibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells

Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis.

[Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].

Deciphering the Exact Sequence of Endogenous Soluble B Cell Maturation Antigen and Unbiased Quantitation in Multiple Myeloma Patient Samples by LC-MS